Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing

Authors

Aaron S. Kesselheim, Harvard Medical School
Steven Woloshin, The Dartmouth Institute for Health Policy and Clinical Practice
Zhigang Lu, Harvard Medical School
Frazer A. Tessema, Harvard Medical School
Kathryn M. Ross, American Board of Internal Medicine
Lisa M. Schwartz, The Dartmouth Institute for Health Policy and Clinical Practice

Document Type

Letter to the Editor

Publication Date

5-1-2019

Journal

JAMA Internal Medicine

Volume

179

Issue

5

DOI

10.1001/jamainternmed.2018.8121

Recommended Citation

Kesselheim, Aaron S.; Woloshin, Steven; Lu, Zhigang; Tessema, Frazer A.; Ross, Kathryn M.; and Schwartz, Lisa M., "Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing" (2019). Biomedical Laboratory Sciences Faculty Publications. Paper 17.
https://hsrc.himmelfarb.gwu.edu/smhs_biomed_facupubs/17